GCell — The Dual-Purpose Regenerative Platform
One intelligent device. Two powerful applications. The GCell Autologous Tissue Separation System by RenuvoGen delivers clinically proven results in both Stromal Vascular Fraction (SVF) therapy and Stem Cell-Powered Hair Restoration — setting a new standard in regenerative medicine.
What Is the GCell?
A Closed-System Autologous Separation Device
The GCell is a CE-marked, single-use, closed-loop autologous tissue separation system designed for point-of-care processing of adipose tissue. By isolating the biologically active stromal vascular fraction (SVF) and stem cell concentrate from a patient's own fat tissue, GCell eliminates donor compatibility risks and enables same-day treatment protocols.
Its compact, tabletop form factor fits seamlessly into clinic environments — no need for expensive cleanroom infrastructure or complex laboratory setups.
2-in-1 Platform
Two Applications. One Device.
The GCell's versatile closed-system architecture supports two distinct — and highly sought-after — regenerative treatment categories, allowing clinics to maximize their investment and serve a broader patient population.
Mesenchymal Stem Cell & Stromal Vascular Fraction (MSC & SVF) Therapy
Harvest and concentrate the body's own regenerative cells from adipose tissue for orthopedic, aesthetic, and anti-aging applications — all within a single clinical session.
Stem Cell Hair Restoration
Deploy autologous stem cell concentrates directly to the scalp to reactivate dormant follicles, stimulate new growth cycles, and deliver lasting, natural hair restoration results.
The Power of Mesenchymal Stem Cells (MSCs)
The GCell system excels at isolating a highly concentrated and viable population of Mesenchymal Stem Cells (MSCs) from the Stromal Vascular Fraction (SVF). These multipotent cells are the engine of regenerative therapy, orchestrating tissue repair, reducing inflammation, and stimulating healing at a cellular level.
Immunomodulatory Effects
MSCs actively modulate the immune system, reducing inflammation and creating an optimal environment for natural tissue repair and regeneration.
Multipotent Differentiation
With the capacity to differentiate into various cell types, including bone, cartilage, muscle, and fat, MSCs are crucial for repairing damaged tissues and restoring function.
Paracrine Signaling
MSCs secrete a powerful cocktail of growth factors, cytokines, and chemokines that stimulate local cells, promote angiogenesis, and recruit other restorative cells to the injury site.
Enhanced Tissue Repair
By combining these actions, MSCs effectively reduce fibrosis, enhance collagen synthesis, and support the body's intrinsic ability to heal and regenerate compromised tissues.
Application 1
Stromal Vascular Fraction (SVF) Therapy
SVF is one of regenerative medicine's most promising frontiers. Derived from the patient's own adipose (fat) tissue, SVF is a rich heterogeneous mixture containing adipose-derived stem cells (ADSCs), endothelial progenitor cells, pericytes, macrophages, and growth factors — all working in concert to trigger tissue repair and regeneration.
The GCell processes lipoaspirate into a concentrated, viable SVF solution ready for injection in as little as 60–90 minutes at the point of care — making it one of the most time-efficient autologous platforms available today.
SVF Clinical Applications
Orthopedics & Joint Regeneration
SVF injections into arthritic or damaged joints have demonstrated significant reductions in pain and inflammation, with improvements in mobility and cartilage health documented across multiple clinical studies.
Aesthetic & Anti-Aging
SVF combined with fat grafting enhances graft survival and improves skin texture, tone, and volume — delivering measurably superior outcomes in facial rejuvenation and body contouring procedures.
Wound Healing & Tissue Repair
The pro-angiogenic and immunomodulatory properties of SVF accelerate healing in chronic wounds, burns, and post-surgical recovery scenarios where conventional therapies have limited efficacy.
How GCell Processes SVF — Step by Step
The entire process occurs within a fully closed, sterile system — minimizing contamination risk and regulatory complexity. No external laboratory transfer is required, enabling same-day treatment in a standard procedure room.
Hair Restoration Protocol Overview
Patient Consultation & Assessment
Evaluate hair loss pattern (Norwood/Ludwig scale), scalp health, and candidacy. Document baseline hair density with trichoscopy or digital imaging for outcome tracking.
Adipose Harvest & GCell Processing
Perform micro-liposuction (typically abdominal or flank region) under local anesthesia. Process 100–150cc lipoaspirate through the GCell to yield concentrated ADSCs and SVF within 90 minutes.
Scalp Micro-Injection
Deliver the autologous concentrate via micro-injections across the treatment zone using a fine-gauge mesotherapy technique. The entire injection session typically takes 30–45 minutes.
Follow-Up & Repeat Sessions
Initial visible improvements in hair density and thickness typically emerge at 3–4 months post-treatment. A protocol of 2–3 sessions per year is recommended for optimal, sustained results.
Application 2
Stem Cell Hair Restoration
Hair loss affects an estimated 80 million Americans, yet most existing treatments address only symptoms — not the underlying biological decline of the follicular microenvironment. RenovGen's GCell-powered hair restoration protocol changes that equation fundamentally.
By deploying autologous stem cells and growth factors directly into the scalp, this approach reactivates dormant follicles, extends the anagen (growth) phase, and improves scalp vascularity — creating the biological conditions necessary for sustained, natural hair regrowth rather than a temporary cosmetic fix.
The Science Behind GCell Hair Restoration
Why Stem Cells Work for Hair Loss
Adipose-derived stem cells (ADSCs) are uniquely suited to hair restoration because they secrete a cocktail of paracrine factors — including VEGF, HGF, KGF, and IGF-1 — that directly stimulate dermal papilla cells, the master regulators of the hair follicle growth cycle.
These growth factors promote angiogenesis in the scalp, increase nutrient delivery to follicles, and shift follicles from the telogen (resting) phase back into active anagen growth — producing measurable increases in hair density and shaft diameter.
Key Biological Mechanisms
VEGF secretion — promotes new blood vessel formation around follicles
Dermal papilla activation — reinitiates stalled growth cycles
Anti-inflammatory signaling — reduces follicular miniaturization
Extracellular matrix remodeling — restores the follicular niche
Clinical Outcomes: Hair Restoration
Clinical evidence from GCell-based autologous stem cell hair restoration protocols demonstrates statistically significant, patient-measurable improvements across key endpoints.
87%
Patient Satisfaction
Reported satisfaction with hair density improvement at 6-month follow-up in multi-center observational data
3–4x
Follicle Activation
Increase in active follicle count versus baseline documented via trichoscopy in stem cell hair restoration cohorts
90 min
Procedure Time
Average total procedure time from harvest to scalp injection — enabling same-day, outpatient treatment
0
Donor Rejection
Zero immunological rejection events — autologous origin eliminates compatibility risk entirely
GCell vs. Traditional Approaches
Understanding how GCell compares to conventional regenerative and hair-restoration modalities clarifies its compelling clinical and operational advantages.
Device Specifications & Features
GCell Technical Overview
Closed-Loop System
Fully sterile, single-use processing cartridge — zero cross-contamination risk between patients
Processing Capacity
Handles 50–300cc lipoaspirate input; yields 3–15cc SVF concentrate depending on volume
Processing Time
Complete SVF isolation in 60–90 minutes — enabling same-day treatment within a standard procedure room
Regulatory Status
FDA cleared for clinical use; compact tabletop design requires no laboratory infrastructure
Why Leading Clinics Choose GCell
Expand Revenue Streams
A single GCell system opens two high-value treatment categories — SVF therapy and hair restoration — without duplicating capital equipment investment. One device, two compelling service lines.
Minimize Regulatory Risk
The closed, autologous processing system keeps GCell within a favorable regulatory framework in most markets — no allogeneic product licensing, no cleanroom requirements, no complex chain-of-custody documentation.
Superior Patient Outcomes
Autologous stem cells and SVF consistently outperform PRP in head-to-head comparisons for hair density improvement and joint pain reduction — giving your clinic a clinically defensible premium positioning.
Streamlined Same-Day Procedures
The 90-minute point-of-care protocol fits within a half-day clinical slot. No patient return visits for laboratory results, no external processing delays — just efficient, premium-experience treatments.
Real Physicians. Real Results.
Regenerative medicine specialists across orthopedics, plastic surgery, and aesthetic medicine have integrated GCell into their practice with consistently strong outcomes.
"GCell has transformed how we approach hair loss in our practice. The ability to offer patients their own stem cells — processed in-house, same day — is a genuine clinical differentiator. Our hair restoration patients are seeing results we simply couldn't achieve with PRP alone."
— Dr. M. Yilmaz, MD, Aesthetic Medicine & Hair Restoration Specialist
"The SVF quality from GCell is consistently high. For our orthopedic patients with knee OA who aren't ready for surgery, this protocol has become a first-line regenerative option. The closed-system design gives us confidence in sterility and reproducibility."
— Dr. A. Kaya, MD, Orthopedic Surgery & Regenerative Medicine
Training, Support & Implementation
🎓 Clinical Training Program
RenuvoGen provides comprehensive hands-on training for physicians and clinical staff — covering patient selection, harvest technique, GCell processing protocol, and injection methodology for both SVF and hair restoration applications.
🔬 Protocol & Marketing Support
Receive ready-to-use clinical protocols, patient consent documentation, treatment tracking templates, and co-branded marketing materials to help you launch and grow your regenerative service line quickly and confidently.
📞 Ongoing Clinical Consultation
Our medical affairs team is available to provide case consultation, outcome review, and continuous education as the clinical evidence base for SVF and stem cell therapies evolves. We're your long-term regenerative medicine partner.
Frequently Asked Questions
Is GCell FDA-cleared?
GCell is FDA cleared and CE Marked for use in U.S. and international markets. The autologous, same-surgical-procedure SVF protocols are generally used within the scope of minimal manipulation guidelines. Talk to your representative to discuss regulatory details..
How much adipose tissue is required?
A minimum of approximately 100cc of lipoaspirate is sufficient for most hair restoration sessions. SVF orthopedic or aesthetic protocols may require 100–200cc depending on the treatment target and desired cell yield.
Can GCell be used alongside other treatments?
Yes. GCell SVF and stem cell concentrate are frequently combined with PRP, hyaluronic acid, microneedling, LLLT (low-level laser therapy), and fat grafting to create synergistic protocols that enhance overall outcomes.
What is the shelf life of the processed SVF?
SVF processed with GCell is intended for same-day, immediate use. The closed-system concentrate should be administered within 4–6 hours of processing to ensure maximum cell viability and clinical efficacy.
Ready to Elevate Your Regenerative Practice?
Join the growing network of forward-thinking clinics offering GCell-powered SVF therapy and autologous stem cell hair restoration. RenuvoGen provides the device, the training, the clinical protocols, and the ongoing support to make your launch seamless and your outcomes exceptional.
📋 Request Clinical Information
Download our full product dossier, clinical evidence compendium, and procedure guides
🏥 Schedule a Virtual Demo
See the GCell system in action with a personalized demonstration at your clinic or our showroom
💬 Speak to a Specialist
Connect directly with a RenuvoGen clinical specialist to discuss your practice goals and patient population